Business Description

Description
CardieX Ltd is a global health technology company, developing solutions for health disorders. The AtCor Medical division develops medical devices for measuring arterial stiffness and central blood pressure waveforms based on its patented SphygmoCor technology. It also develops and licenses its Arty platform consisting of physiological and health analytics for wearable devices. It reports in a single segment being sales of cardiovascular devices and services to hospitals, clinics, research institutions, and pharmaceutical companies. The company has three reportable segments by geographic area namely the Americas includes, global pharmaceutical trials business, Europe includes, the Middle East and Africa and the Asia Pacific includes, Asia and Australia/New Zealand.
Name Current Vs Industry Vs History
Cash-To-Debt 1.09
Debt-to-Equity 388.5
Debt-to-EBITDA -1
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -11.56
Distress
Grey
Safe
Beneish M-Score -4.38
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.02
Quick Ratio 0.85
Cash Ratio 0.65
Days Inventory 744.36
Days Sales Outstanding 31.71
Days Payable 2374.83

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -24
Shareholder Yield % -62.4
Name Current Vs Industry Vs History
Gross Margin % 92.76
Operating Margin % -77.59
Net Margin % -74.45
FCF Margin % -42.95
ROE % -739.24
ROA % -61.91
ROIC % -110.48
ROC (Joel Greenblatt) % -658.67
ROCE % -334.86

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 0.63
EV-to-EBIT -1.78
EV-to-EBITDA -1.78
EV-to-Revenue 1.2
EV-to-FCF -2.8
Earnings Yield (Greenblatt) % -56.18
FCF Yield % -34.07

Financials

CDEXF's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:CDEXF

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

CardieX Ltd Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 8.463
EPS (TTM) ($) -0.04
Beta 1.73
Volatility % 0
14-Day RSI 0
14-Day ATR ($) 0
20-Day SMA ($) 0.4
12-1 Month Momentum % 0
52-Week Range ($) 0.4 - 0.4
Shares Outstanding (Mil) 294.17

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

CardieX Ltd Filings

Filing Date Document Date Form
No Filing Data

CardieX Ltd Stock Events

Financials Calendars
Event Date Price($)
No Event Data

CardieX Ltd Frequently Asked Questions

What is CardieX Ltd(CDEXF)'s stock price today?
The current price of CDEXF is $0.40. The 52 week high of CDEXF is $0.40 and 52 week low is $0.40.
When is next earnings date of CardieX Ltd(CDEXF)?
The next earnings date of CardieX Ltd(CDEXF) is .
Does CardieX Ltd(CDEXF) pay dividends? If so, how much?
CardieX Ltd(CDEXF) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1